Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Nuevolution in connection with a directed share issue
Mandate

Vinge advises Nuevolution in connection with a directed share issue

May 25, 2018

The board of directors of Nuevolution has resolved on a directed new issue of shares, whereby Nuevolution will raise proceeds of approximately SEK 110 million, before issue costs.

The share issue is directed to a number of selected Swedish and international investors, on the basis of an accelerated bookbuilding process conducted by Carnegie Investment Bank AB (publ) and Redeye AB.

Nuevolution AB (publ) is a small molecule drug discovery biotech company. The company’s shares are admitted to trading on Nasdaq First North Premier.

Vinge’s team has consisted of Dain Hård Nevonen, David Andersson, Malte Hedlund and Stephanie Stiernstedt.

Related

Vinge advises Active Biotech in connection with rights issue

 Vinge advises Active Biotech AB (publ) in connection with a rights issue of approximately SEK 43 million.
November 29, 2024

Vinge advises ABGSC and SEB in connection with Europi’s inaugural issuance of green bonds

Vinge has advised the joint arrangers in connection with Europi Property Group AB (publ)’s (the "Company") inaugural issue of EUR 50 million senior unsecured green bonds within a framework of up to EUR 100 million. The bonds carry a floating interest rate of EURIBOR 3M + 5.00% and have a tenor of three years. The Company intends to apply for admission to trading of the new bonds on Nasdaq Transfer Market and the sustainable bond list of Nasdaq Stockholm.
November 29, 2024

Vinge advises Rieber & Søn in connection with its acquisition of Accept Försäkringsaktiebolag (publ)

 Accept, with headquarter in Stockholm, has been an innovator in the Swedish insurance market since its formation in 1998. The company was the first with offering loss of income insurance and has since offered products that complement the general insurance offering. Today, Accept delivers web-based insurance solutions customised for its offering.
November 21, 2024